TY - JOUR
T1 - Endoscopic hand-suturing is feasible, safe, and may reduce bleeding risk after gastric endoscopic submucosal dissection
T2 - a multicenter pilot study (with video)
AU - Goto, Osamu
AU - Oyama, Tsuneo
AU - Ono, Hiroyuki
AU - Takahashi, Akiko
AU - Fujishiro, Mitsuhiro
AU - Saito, Yukata
AU - Abe, Seiichiro
AU - Kaise, Mitsuru
AU - Iwakiri, Katsuhiko
AU - Yahagi, Naohisa
N1 - Funding Information:
DISCLOSURE: The following authors have ties with Olympus Co Ltd as a consultant, O.G., T.O., H.O., M.F., N.Y.; a paid speaker, O.G., H.O., M.F.; and a royalty fee holder N.Y. Research support for this study was provided to O.G. by a grant-in-aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology in Japan (2018-2020, grant no. 18K07919) and by Olympus Co Ltd (flexible needle holder and scissors forceps).
Publisher Copyright:
© 2020 American Society for Gastrointestinal Endoscopy
PY - 2020/5
Y1 - 2020/5
N2 - Background and Aims: Endoscopic hand-suturing (EHS) provides secure intraluminal mucosal closure and should decrease the risk of adverse events after gastric endoscopic submucosal dissection (ESD). We prospectively investigated the feasibility and safety of EHS after gastric ESD, particularly for preventing post-ESD bleeding. Methods: Patients scheduled for gastric ESD at 3 institutions were prospectively recruited. Just after ESD, the mucosal defect was closed by EHS. The primary outcome was endoscopic assessment of adequately sustained closure of the defect on postoperative day 3. Endoscopy was performed to assess maintenance of the closure for the primary outcome. During postoperative weeks 3 to 4, patients were interviewed as outpatients about any occurrence of delayed bleeding. Results: Data from 30 patients (15 each who did or did not take antithrombotic agents) were analyzed. Mucosal closure by EHS was completed in 29 of 30 cases (97%) and was well maintained on postoperative day 3 in 25 cases (84%). Emergency endoscopy was required for major postoperative bleeding in 3 cases (10%), including 1 in which suturing had been incomplete. Excluding 1 patient with a remnant stomach, the other 24 with sustained closure had no bleeding, regardless of whether they did or did not take antithrombotic agents (0/11 and 0/13, respectively). No serious adverse events occurred during EHS. Conclusions: Results show that EHS is feasible and safe with favorable outcomes. Provided that mucosal suturing is successfully completed and sustained, post-ESD bleeding can be decreased even in patients undergoing antithrombotic therapy. (Clinical trial registration number: UMIN 000033988.)
AB - Background and Aims: Endoscopic hand-suturing (EHS) provides secure intraluminal mucosal closure and should decrease the risk of adverse events after gastric endoscopic submucosal dissection (ESD). We prospectively investigated the feasibility and safety of EHS after gastric ESD, particularly for preventing post-ESD bleeding. Methods: Patients scheduled for gastric ESD at 3 institutions were prospectively recruited. Just after ESD, the mucosal defect was closed by EHS. The primary outcome was endoscopic assessment of adequately sustained closure of the defect on postoperative day 3. Endoscopy was performed to assess maintenance of the closure for the primary outcome. During postoperative weeks 3 to 4, patients were interviewed as outpatients about any occurrence of delayed bleeding. Results: Data from 30 patients (15 each who did or did not take antithrombotic agents) were analyzed. Mucosal closure by EHS was completed in 29 of 30 cases (97%) and was well maintained on postoperative day 3 in 25 cases (84%). Emergency endoscopy was required for major postoperative bleeding in 3 cases (10%), including 1 in which suturing had been incomplete. Excluding 1 patient with a remnant stomach, the other 24 with sustained closure had no bleeding, regardless of whether they did or did not take antithrombotic agents (0/11 and 0/13, respectively). No serious adverse events occurred during EHS. Conclusions: Results show that EHS is feasible and safe with favorable outcomes. Provided that mucosal suturing is successfully completed and sustained, post-ESD bleeding can be decreased even in patients undergoing antithrombotic therapy. (Clinical trial registration number: UMIN 000033988.)
UR - http://www.scopus.com/inward/record.url?scp=85081227294&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081227294&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2019.12.046
DO - 10.1016/j.gie.2019.12.046
M3 - Article
C2 - 31923410
AN - SCOPUS:85081227294
SN - 0016-5107
VL - 91
SP - 1195
EP - 1202
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 5
ER -